Many of the factors required for chromosomal DNA replication have been identified in unicellular eukaryotes. However, DNA replication is poorly understood in multicellular organisms. Here, we report the identification of GEMC1 (geminin coiled-coil containing protein 1), a novel vertebrate protein required for chromosomal DNA replication. GEMC1 is highly conserved in vertebrates and is preferentially expressed in proliferating cells. Using Xenopus laevis egg extract we show that Xenopus GEMC1 (xGEMC1) binds to the checkpoint and replication factor TopBP1, which promotes binding of xGEMC1 to chromatin during pre-replication complex (pre-RC) formation. We demonstrate that xGEMC1 interacts directly with replication factors such as Cdc45 and the kinase Cdk2-CyclinE, through which it is heavily phosphorylated. Phosphorylated xGEMC1 stimulates initiation of DNA replication, whereas depletion of xGEMC1 prevents the onset of DNA replication owing to the impairment of Cdc45 loading onto chromatin. Similarly, downregulation of GEMC1 expression prevents DNA replication in embryonic and somatic vertebrate cells. These data suggest that GEMC1 promotes initiation of chromosomal DNA replication in multicellular organisms by mediating TopBP1-and Cdk2-dependent recruitment of Cdc45 onto replication origins.
GEMC1 is a TopBP1-interacting protein required for chromosomal DNA replication Alessia Balestrini 1 , Claudia Cosentino 1 , Alessia Errico 2 , Elizabeth Garner 1 and Vincenzo Costanzo 1, 3 Many of the factors required for chromosomal DNA replication have been identified in unicellular eukaryotes. However, DNA replication is poorly understood in multicellular organisms. Here, we report the identification of GEMC1 (geminin coiled-coil containing protein 1), a novel vertebrate protein required for chromosomal DNA replication. GEMC1 is highly conserved in vertebrates and is preferentially expressed in proliferating cells. Using Xenopus laevis egg extract we show that Xenopus GEMC1 (xGEMC1) binds to the checkpoint and replication factor TopBP1, which promotes binding of xGEMC1 to chromatin during pre-replication complex (pre-RC) formation. We demonstrate that xGEMC1 interacts directly with replication factors such as Cdc45 and the kinase Cdk2-CyclinE, through which it is heavily phosphorylated. Phosphorylated xGEMC1 stimulates initiation of DNA replication, whereas depletion of xGEMC1 prevents the onset of DNA replication owing to the impairment of Cdc45 loading onto chromatin. Similarly, downregulation of GEMC1 expression prevents DNA replication in embryonic and somatic vertebrate cells. These data suggest that GEMC1 promotes initiation of chromosomal DNA replication in multicellular organisms by mediating TopBP1-and Cdk2-dependent recruitment of Cdc45 onto replication origins.
To initiate DNA replication, the pre-RC is assembled by loading complexes such as ORC1-6 and the MCM2-7 helicase, together with Cdc6 and Cdt1, onto chromatin. Origin firing is triggered by the Cdk2-CyclinE and Cdc7-Dbf4 kinases, which in the presence of Mcm10, TopBP1 and the GINS complex 1,2 , promote loading of Cdc45 and polymerases. To identify novel proteins with a role in chromosomal DNA replication in multicellular organisms, we performed database searches for open reading frames (ORFs) containing degenerate signature motifs present in known replication factors. We identified an ORF that we named GEMC1 (geminin coiled-coil containing protein 1), as it contains a region similar to the coiled-coil domain of geminin, an essential vertebrate replication protein in which the coiled-coil domain is required for function 3 (Fig. 1a and Supplementary Information, Fig. S1a ). Figure 1b shows that GEMC1 is highly conserved in vertebrates, as close homologues can be found in Homo sapiens (hGEMC1), Mus musculus (mGEMC1), Rattus norvegicus (rGEMC1) and Xenopus laevis (xGEMC1). However, only some of the amino-acid residues critical for geminin function are conserved in GEMC1 (ref. 4 ). In addition, comparison of the predicted GEMC1 structure with geminin revealed an interruption in the coiledcoil domain of GEMC1 ( Supplementary Information, Fig. S1b ).
We isolated xGEMC1 cDNA from Xenopus mRNA and used the Xenopus egg extract system 5, 6 to investigate whether recombinant xGEMC1, in common with endogenous geminin, could inhibit DNA replication 3 . No significant inhibition of chromosomal DNA replication was observed when physiological amounts of xGEMC1 were added to egg extract ( Supplementary Information, Fig. S1c ), suggesting that xGEMC1 has a different role from geminin.
To identify the function of xGEMC1, we generated polyclonal antibodies against recombinant xGEMC1 fusion proteins (Fig. 1c ). xGEMC1 is expressed in most Xenopus tissues ( Supplementary Information,  Fig. S1d ): its expression pattern partially overlaps other replication factors, such as MCM7, Cdk2 and TopBP1 (data not shown), and it is enriched in proliferating cells from skin and gut (although it was also detected in ovary, brain and lung tissues; Supplementary Information, Fig. S1d ). Analysis in egg extract revealed that xGEMC1 can bind to chromatin at an early stage of DNA replication, although its accumulation progresses more slowly than other replication factors ( Fig. 2a ). xGEMC1 binding is independent of the MCM2-7 complex as it can be detected on chromatin in the presence of recombinant geminin, which suppresses MCM2-7 loading without affecting binding of other factors such as TopBP1 (refs 2, 3, 7; Fig. 2a ). Furthermore, xGEMC1 loading was minimally affected by the Cdk2 inhibitor p27 (refs 2, 3, 7; Fig. 2a ). Depletion of Cdc45 did not impair binding of xGEMC1 to chromatin, but did prevent loading of the GINS complex (data not shown).
To investigate the role of xGEMC1 in DNA replication, we depleted it from egg extract ( Fig. 2b) , or supplemented extract with affinitypurified antibodies specific for xGEMC1 to interfere with its function. These treatments inhibited chromosomal DNA replication but did not affect origin-independent replication of the single-stranded M13 phage ( Fig. 2c-e and Supplementary Information, Fig. S1e ). Inhibition of DNA replication was rescued by adding recombinant xGEMC1 to depleted egg extract or by out-competing anti-xGEMC1-neutralizing antibodies with an excess of recombinant xGEMC1 (r-xGEMC1; Fig. 2c , d and Supplementary Information, Fig. S1e ). The anti-xGEMC1 antibodies did not crossreact with geminin (Supplementary Information, Fig. S1f) or affect nuclear membrane formation, which is required for chromosomal DNA replication 8 ( Supplementary Information,  Fig. S2a ). xGEMC1 depletion prevented Cdc45 and Sld5 from binding to chromatin, whereas addition of recombinant xGEMC1 restored binding ( Fig. 2f ). Consistently, anti-xGEMC1-neutralizing antibodies prevented Cdc45 chromatin loading ( Supplementary Information,  Fig. S2b ). TopBP1, Cdc7, ORC1-6 and MCM2-7 complex loading was unaffected by xGEMC1 depletion or anti-xGEMC1 antibodies ( Fig. 2f and Supplementary Information, Fig. S2c ). These data indicate that following its binding to chromatin, xGEMC1 is required for loading of Cdc45 and the GINS complex onto replication origins.
To identify xGEMC1-binding partners involved in DNA replication, a pull-down experiment was performed with recombinant xGEMC1 fused to maltose-binding protein (MBP) and incubated in egg extract, resulting in coprecipitation of Cdc45, CyclinE and Cdk2 (Fig. 3a) . These interactions were specific, as xGEMC1 did not interact with factors such as Cdc7 and Sld5 ( Supplementary Information, Fig. S2d ). Furthermore, xGEMC1 did not interact with geminin partner Cdt1 ( Fig. 3a) , consistent with the fact that amino-acid residues required for Cdt1 binding 4 are absent in xGEMC1. We used recombinant proteins to investigate whether any of these interactions were direct. Recombinant xGEMC1 interacted directly with Cdc45 and the Cdk2-CyclinE complex in vitro ( Supplementary Information, Fig. S3a, b ). These interactions also occurred endogenously, as shown by coprecipitation of xGEMC1 with anti-Cdc45 antibodies ( Supplementary Information, Fig. S3c ) and with p13-Suc1 affinity resin for Cdks 9 (Supplementary Information, Fig. S3d ). Recombinant xGEMC1 also interacts with TopBP1 (Mus101 in Drosophila melanogaster; Dpb11 in Saccharomyces cerevisiae), which is an essential component of the DNA replication machinery 2,7 , in extract and in vitro (Fig. 3b ). The interaction was detected endogenously in xGEMC1 and TopBP1 immunoprecipitates ( Supplementary  Information, Fig. S3e , f). Depletion of TopBP1 inhibited xGEMC1 loading onto chromatin during early stages of pre-RC formation, indicating that TopBP1 is directly required for binding of xGEMC1 to chromatin ( Fig. 3c ). Taken together, these data indicate that TopBP1-dependent loading of xGEMC1 during pre-RC assembly promotes the subsequent binding of Cdc45 to chromatin. Residual TopBP1-independent binding of xGEMC1 to chromatin after initiation of DNA replication was also observed, suggesting that xGEMC1 has additional binding partners on DNA that are not directly involved in replication initiation ( Fig. 3c ).
Importantly, binding of xGEMC1 to chromatin was dependent on the ORC1-6 complex, as depletion of ORC1 prevented xGEMC1 binding to chromatin (Fig. 3d ).
The interaction of xGEMC1 with Cdk2-CyclinE prompted us to verify whether xGEMC1 is also a substrate for Cdk2. xGEMC1 is heavily phosphorylated in vitro by Cdk2-CyclinE ( Fig. 3e ) and by Cdk2-CyclinA ( Supplementary Information, Fig. S3g ). Multiple phosphorylated forms of xGEMC1 that were sensitive to lambda phosphatase treatment and roscovitine 10 (data not shown) were observed when 35 S-labelled xGEMC1 was incubated in egg extract ( Supplementary Information, Fig. S3h ). These results suggest that xGEMC1, in common with other replication proteins 1, 11 , is a Cdk substrate in egg extract. We then tested whether the cyclin-binding site R198NL (Arg-X-Leu, where X is any residue) 12 present at the carboxyl terminus of xGEMC1 was required for the phosphorylation. Mutation of R198NL to A198NA (Ala-X-Ala, where X is any residue) strongly reduced phosphorylation by Cdk2 ( Fig. 3e and Supplementary Information, Fig. S3g, h) . The cyclin-binding domain was also required for the interaction between xGEMC1 and the Cdk2-CyclinE complex, as this was abolished by the A198NA mutation without affecting the interaction with Cdc45 ( Supplementary Information, Fig. S3i ). Phosphorylation assays using xGEMC1 peptide arrays revealed a major Information, Fig. S4b ) recognised endogenous xGEMC1 phosphorylation on Thr 153 ( Supplementary Information, Fig. S4c ). However, xGEMC1 lacking Thr 153 could still be phosphorylated by Cdk2 in vitro ( Supplementary Information, Fig. S4d ). Therefore, we mutated seven of the eight putative Cdk sites that could be phosphorylated by Cdk2-CyclinE and Cdk2-CyclinA in the absence of Thr 153 ( Supplementary Information, Fig. S4d ). As expected for a Cdk target bearing a strong cyclin-binding domain, only combined mutations of the additional Cdk sites completely suppressed phosphorylation of xGEMC1 by Cdk2 ( Supplementary Information, Fig. S4e ). As multiple phosphorylated forms of xGEMC1 protein were detected in egg extract ( Supplementary Information, Fig. S3h ), it is probable that these sites are also phosphorylated by Cdk2 in vivo.
Next, we assessed the role of xGEMC1 phosphorylation by Cdk2 in DNA replication. Extracts have a limited ability to support full replication of a high amount of sperm nuclei ( Fig. 3f and refs 13, 14) , owing to limiting Cdk activity 14 and to the activation of the ATM/ ATR checkpoint that represses Cdk2-dependent origin firing 15 . As xGEMC1 is a Cdk2 target required for DNA replication, we tested whether it is a limiting factor for replication of high amounts of sperm nuclei. We supplemented egg extract with an excess of recombinant xGEMC1 bearing putative Cdk2 serine-threonine phosphorylation sites mutated to aspartate (xGEMC1-8ST-D) or alanine (xGEMC1-8ST-A) residues to mimic constitutively phosphorylated and un-phosphorylatable proteins, respectively. The replication of the absolute amount of DNA template added to egg extract was then monitored. Under these conditions, xGEMC1-8ST-D, but not xGEMC1-8ST-A, stimulated efficient replication of a high concentration of sperm nuclei (Fig. 3f ). xGEMC1-8ST-D-dependent stimulation was also observed in the presence of the ATM/ATR pathway inhibitor caffeine 15 , indicating that it was not caused by downregulation of the ATM/ATR checkpoint (Fig. 3f ). The increase in DNA replication was accompanied by enhanced loading of Cdc45 (Fig. 3g ). DNA replication kinetics ( Fig. 3f ) and replication fork rate, as measured by DNA fibre spreading analysis ( Supplementary Information, Fig. S5a ), were not significantly affected by xGEMC1-8ST-D. In addition, analysis of DNA replication products on CsCl gradients excluded the presence of re-replication in the presence of xGEMC1-8ST-D ( Supplementary Information, Fig. S5b ). Collectively, these results suggest that the increase in DNA replication mediated by xGEMC1-8ST-D is caused by enhanced origin firing.
Intriguingly, xGEMC1-8ST-D showed higher affinity for TopBP1, whereas the binding of xGEMC1-8ST-A to TopBP1 was decreased siRNA-resistant HA-tagged mGEMC1 (mGEMC1* rescue). Cells were subjected to silencing with mGEMC1_1 siRNA in the absence or presence of 1 μg ml -1 doxycycline (Dox), which represses the expression driven by the exogenous promoter present on the vector. After 96 h, cells were collected and processed for western blot using anti-HA and anti-GAPDH antibodies as indicated. (f) Percentage of MEF-3T3 cells in S phase that were treated with mock or mGEMC1 siRNA oligos. mGEMC1_1 siRNA treated cells were stably transfected with empty TET-OFF vector (Vector), with TET-OFF vector expressing HA-tagged mGEMC1 (mGEMC1) or with the same vector expressing siRNA-resistant HA-tagged mGEMC1 (mGEMC1*) in the absence (-Dox) or presence (+Dox) of 1 μg ml -1 doxycycline. Cells were labelled with BrdU and processed for FACS analysis. The graph shows data from one representative experiment. (g) Model for GEMC1 function at replication origins (see text for explanation). See Supplementary Information, Fig. S6 , for uncropped gels shown in this figure.
(although not abolished; Fig. 3h ). To confirm a role for phosphorylation of xGEMC1, we monitored DNA replication in extracts depleted of xGEMC1 and supplemented with physiological amounts of xGEMC1-8ST-A or xGEMC1-8ST-D mutant proteins. xGEMC1-8ST-A could not restore DNA replication, whereas xGEMC1-8ST-D induced a significant increase in DNA replication ( Supplementary Information, Fig. S5c, d) . xGEMC1-8ST-D was unable to completely bypass the requirement for Cdk2 in DNA replication, as it did not restore DNA replication in extract where Cdk2 activity was inhibited by roscovitine 10 (data not shown). This suggests that xGEMC1 is not the only Cdk2 target required for initiation of DNA replication. Overall, these data indicate that xGEMC1 is involved in promoting initiation of DNA replication by mediating TopBP1-and Cdk2-dependent loading of Cdc45 onto replication origins. To validate these results, we depleted xGEMC1 protein from Xenopus embryos by selectively inactivating xGEMC1 expression with morpholino antisense (MO) oligos 16 . We selected MO oligos that inhibited xGEMC1 translation in the reticulocyte system (xGEMC1 MO; Supplementary Information,  Fig. S5e ). When injected into fertilized eggs, xGEMC1 MO oligos inhibited xGEMC1 expression, whereas control MO oligos did not (Fig. 4a ). Depletion of xGEMC1 induced a severe delay in embryo development and gross anatomical defects, with poor yolk resorption and no distinct structures such as the gut, optic vesicle or tail. These defects were detected in most embryos injected with xGEMC1 MO oligos (Fig. 4b, c) . The most significant effects were detected after complete downregulation of xGEMC1 protein levels around neurula stage (Fig. 4b) . The delayed effects of MO oligos were probably caused by the persistence of high xGEMC1 protein levels up to late developmental stages. Histological analysis revealed a marked decrease in cell density and DNA content when xGEMC1 was inhibited ( Fig. 4d, e ). This was accompanied by induction of apoptosis ( Fig. 4f ).
To confirm that xGEMC1 has a role in DNA replication in mammalian organisms, we isolated the mouse homologue of GEMC1 (mGEMC1) and assessed mRNA levels by RT-PCR (Fig. 5a) . A decrease in mGEMC1 mRNA obtained with siRNA oligos (Fig. 5a, b ) led to severe inhibition of cell proliferation (Fig. 5c, d) . The extent of inhibition was similar to that obtained by inhibiting Cdc45 expression ( Fig. 5c, d and Supplementary  Information, Fig. S5f ). Ectopic expression of RNAi-resistant mGEMC1 protein, obtained by introducing silent mutations into the cDNA of mGEMC1 and expressing it under the control of a doxycycline-regulated promoter, restored proliferation in mGEMC1-silenced cells (Fig. 5e, f) .
Here we have identified GEMC1, a novel vertebrate protein required for initiation of DNA replication. GEMC1 interacts directly with TopBP1, Cdc45 and Cdk2-CyclinE. Recruitment of Cdc45 onto DNA has been shown to be promoted by Cdk2, Cdc7, MCM10, the GINS complex and TopBP1 (refs 17-20) . xGEMC1 is required for binding of Cdc45 to chromatin, which promotes origin unwinding, recruitment of RPA (single-strand-binding replication protein A) and loading of DNA polymerase α (refs 21, 22) . Continuous accumulation of xGEMC1 on chromatin, observed after Cdc45 loading, suggests that xGEMC1 also has other functions in addition to DNA replication.
Although xGEMC1 has a coiled-coil domain with some similarities to geminin, it does not function in the same way. In S. cerevisiae, a complex made by Sld2, Sld3 and Dpb11 is essential to trigger DNA replication initiation 23, 24 . Emerging evidence shows that these two proteins represent the minimal set of S phase Cdk substrates required for DNA replication 23, 24 . Sld3 interacts with Cdc45 and is required for chromatin binding 25, 26 . Phosphorylation of Sld3 by S phase Cdks promote its binding to Dpb11-TopBP1 (refs 23, 24, 27) . To date, a Sld2 homologue in vertebrates has been identified, and corresponds to RecQL4 (refs 28, 29) . Sld3 is poorly conserved, even within fungi, suggesting this protein evolved rapidly. Although the Schizosaccharomyces pombe version of Sld3 has coiledcoil domains, no significant amino-acid similarity was detected between S. Pombe or S. cerevisiae Sld3 and GEMC1. However, in common with S. cerevisiae Sld3, xGEMC1 is phosphorylated by S phase Cdks, interacts with Cdc45 and TopBP1 and is required for Cdc45 loading onto chromatin (Fig. 5g) . Importantly, xGEMC1 constitutively phosphorylated on Cdk sites has higher affinity for TopBP1, and stimulates Cdc45 chromatin loading and initiation of DNA replication. This indicates that similarly to Sld3 (refs 23, 24), phosphorylation of xGEMC1 by Cdk2 is important for origin firing. It is tempting to speculate that GEMC1 represents a functional vertebrate homologue of yeast Sld3. The absence of protein sequence conservation with Sld3 might reflect the fact that during evolution, the function of Sld3 and xGEMC1 has evolved dynamically to adapt to the individual needs of origin firing control in each species. Alternatively, GEMC1 might not be the only protein with these properties, as other factors (together or in addition to GEMC1), might be required to mediate the interaction between TopBP1, Cdc45 and Cdk2 at replication origins. Further study of GEMC1 will lead to a better understanding of normal and uncontrolled cell-cycle progression in vertebrate organisms.
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METHoDS Xenopus egg extract and chromatin isolation. S phase extract and demembranated sperm nuclei were prepared as previously described 30 . To isolate chromatin, sperm nuclei (3-4,500 nuclei μl -1 ) were added to 50 μl egg extract for the indicated times. The sample collected at time zero was DNA-free. Roscovitine (Calbiochem) was used at 500 μM. Recombinant geminin was used at 80 nM (a gift from T. Hunt). Caffeine (Sigma) was used at 3 mM. For immunoblotting, samples were diluted with ten volumes EB buffer (100 mM KCl, 2.5 mM MgCl 2 and 50 mM Hepes KOH at pH 7.5) containing 0.25% Nonidet P-40 and centrifuged through a 30% sucrose layer at 10,000g at 4 °C for 5 min using a swing-out bucket rotor, washed with 500 μl EB buffer and centrifuged again at 10,000g for 5 min in a fixed-angle rotor. The pellet was resuspended in Laemmli loading buffer and the proteins were resolved by 10% SDS-PAGE and analysed by western blotting with specific antibodies, as indicated.
Pull-downs.
For pull-down assays, MBP or MBP-xGEMC1 recombinant protein (3 μg) was incubated with 200 μl extract or 50 ng μl -1 Cdk2-CyclinE complex at 23 °C for 30 min. Amylose resin (60 μl) was added to the reactions that were then diluted with 700 μl PBS containing 0.4% Triton X-100. After incubation for 2 h at 4 °C, beads were harvested, washed extensively with PBS supplemented with 600 mM NaCl and 4% Triton X-100, before processing for SDS-PAGE.
To perform in vitro pull-down assays, 3 μl 35 S-labelled GEMC1 (synthesised by in vitro transcription translation; IVTT) was added to 100 μl conjugation buffer (PBS containing 0.5% Triton X-100) in the presence or absence of 6×His-Cdc45 (2 μg) conjugated to 10 μl Ni-NTA (nickel-chelate-nitrilotriacetic acid) agarose (Qiagen). After incubation for 2 h at 4 °C, beads were recovered and washed five times with wash buffer (50 mM imidazole, 50 mM Hepes-KOH at pH 7.5, 600 mM NaCl and 0.5% Triton). 6×His-TopBP1 recombinant protein was expressed in baculovirus-infected Sf9 cells by the LRI cell culture facility. 6×His-TopBP1 (50 ng μl -1 ) was incubated in 100 μl EB-0.5% Triton buffer in the presence of MBP, MBP-xGEMC1 or MBP-xGEMC1-8ST/D proteins pre-bound to amylose resin. Samples were incubated for 45 min at 4 °C. Beads were collected and washed extensively with EB buffer supplemented with 0.5% Triton X-100. Laemmli buffer was added and samples were boiled and processed for SDS-PAGE and western blotting.
In vitro transcription translation (IVTT) and kinase assays. 35 S-labelled xGEMC1 and xGEMC1 R198NL proteins were synthesized using Quick Couple SP6 kit (Promega Corp.). In vitro kinase assays were performed by incubating 5 μl in vitro translated 35 S-labelled xGEMC1 and xGEMC1 R198NL in 20 μl kinase buffer (80 mM β-glycerolphosphate, 0.5 mM EGTA, 100 μM ATP and 2.5 mM MgCl 2 ) in the presence or absence of 100 nM recombinant Cdk2-Cyclin E (a gift from T. Hunt, Clare Hall laboratories, London, UK) at 23 °C for 30 min. 35 S-labelled xGEMC1 and xGEMC1 R198NL proteins were also incubated in egg extract at 23 °C for 30 min in the presence of lambda phosphatase (NEB), lambda phosphatase buffer or 1 mM roscovitine (Calbiochem) to detect endogenous phosphorylation.
Antibodies. Rabbit Xenopus GEMC1 antiserum was generated by Biogenes (Berlin, Germany) against recombinant 6×His-tagged xGEMC1 protein expressed in bacteria. Sixteen rabbits were injected. Immunoglobulins specific for xGEMC1 were purified according to standard procedures. Only one rabbit serum was able to deplete xGEMC1. Rabbit polyclonal antibodies against Xenopus TopBP1, geminin and Sld5 were a gift from H. Takisawa (Osaka University, Japan). Mouse monoclonal antibodies against Mcm7 were purchased from Santa Cruz (SC-9966). Polyclonal antibodies against 6×Histidine tag were from Cell Signaling. Antibodies against Xenopus Cdk2, CyclinE, Orc1 and Orc2 were a gift from J. Gannon (Clare Hall laboratories, London, UK). Antibodies against Xenopus Cdt1 were a gift from J. Walter (Harvard University, USA). Anti-Cdc45 antibodies were a gift from J. Gautier (Columbia University, USA). The western blot procedures were performed using ECL or ECL plus (Amersham). Antibodies for western blots were used at 1:1,000 dilution unless otherwise specified.
Production of recombinant proteins. Full-length xGEMC1 was obtained from a Xenopus maternal cDNA by race-PCR (Invitrogen) according to manufacturer's instructions, using degenerate oligos annealing to the conserved coiled-coil region.
To generate MBP-and GST (glutathione S-transferase)-tagged GEMC1 recombinant proteins, full-length xGEMC1 was amplified by PCR using a 5´ primer containing a restriction site for BamHI: 5´-GGATCCAA CACTATTCTA AC-TTGCCAAGACGAG-3´ and a 3´ primer containing a restriction site for SalI:
5´-GTCGA CGCTCATTCAGACTGCTTGGGCACCCAAGTGAACTTCC -3´. The PCR product was cloned into pCR-BluntII TOPO vector (Invitrogen).
The amplified cDNA was subsequently digested with BamHI-SalI and BamHI-NotI and subcloned into pMAL-c4X vector (Invitrogen) and pGEX-6P-1 vector (GE-healthcare), respectively. MBP-and GST-tagged GEMC1 were expressed in BL21-A1 cells (Invitrogen) and purified on amylose resin or glutathione Sepharose 4B resin (Amersham) according to manufacturer's instructions.
6×His-xGEMC1 was generated using Gateway technology (Invitrogen). The full-length ORF of GEMC1 was generated by PCR as previously described, using the following primers: 5´ primer: 5´-CACCAA CAC TATT CTAACTT-GCCAAGACGAGTACTTTGC-3´ and 3´ primer: 5´-TCATT CAG ACTGCTTG-GGCACCCAAGTGAACTTCC-3´.
The amplified PCR product was cloned into the pENTR vector (Invitrogen) by Gateway technology and transferred to destination vectors with Histidine-tag (pDEST17, Invitrogen). Recombinant protein was expressed in BL21-CodonPlus (DE3)-RIL cells (Stratagene) and purified on a Ni-NTA column (Qiagen) in denaturing conditions according to manufacturer's instructions.
Site-directed mutagenesis (Stratagene) was used to generate xGEMC1-ANA and single/multiple, serine/threonine to alanine and aspartate mutant xGEMC1-8ST/D proteins. xGEMC1 proteins used in these experiments were also defective for the cyclin-binding domain (R198NL to A198NA mutation) to avoid titration of endogenous Cdk2-Cyclin E complex.
Baculovirus encoding 6×His-TopBP1 (a gift from H. Takisawa) and 6×His-Cdc45 (a gift from J. Gautier) were used to infect Sf9 cells, which were expanded in flasks using complete GRACE medium (Invitrogen) according to manufacturer's instructions. p27 protein was a gift from T. Hunt.
Nuclear morphology. For nuclear morphology, 1 μl extract supplemented with 3000 nuclei μl -1 was diluted 10-fold with fixative solution (EB buffer containing 1% formaldehyde, 1 mg ml -1 DAPI and 1 μg ml -1 fluorescent membrane dye 3,3´-dihexyloxacarbocyanine iodide, DiOC6) and spotted on glass slides. Images were examined by optical microscopy.
Embryo microinjections. Xenopus embryos were obtained by in vitro fertilization as previously described 31 . Whole embryos were dejellied with 2% cysteine hydrochloride at pH 8.0, maintained in 1/15×normal amphibian medium (NAM) 32 and staged as previously described 33 . Embryos for injections were transferred to 3/4×NAM containing 4% Ficoll 400, and injected at the one-cell stage into the animal pole with 97 ng of control scrambled morpholino oligos (MOs) or a 50% mixture of antisense morpholino oligos specific for xGEMC1.
The following antisense MOs were used: 5´-CTTGGCAA GTTAG AATA-GTGTTCAT-3´ (xGEMC1.1), 5´-GTTCCTGG CAGGCAG GCACCT TTTC-ATTG-3´ (xGEMC1.2). MOs were obtained from Gene Tools (Philomath).
Peptide arrays. Peptides (30mer) derived from the xGEMC1 sequence were screened for phosphorylation sites. Starting from the N terminus, each 30mer peptide in the array was advanced from the previous by two residues in the C-terminal direction. Peptides were arrayed on nitrocellulose membranes (LRI protein chemistry facility). xGEMC1 peptide arrays were incubated with EB kinase buffer with or without Cdk2-CyclinE complex in the presence of 50 μM ATP and 10 μCi of γ-32 P-ATP at 30 °C for 60 min. Membranes were then washed with EB buffer and exposed for autoradiography.
Anti-phospho antibodies. N-terminal 20mer xGEMC1 peptides containing phosphorylated Thr 153 at position eight (CPFSSNST(p)PGSKAKRARRNL) were conjugated to keyhole limpet hemocyanin (KLH; Pierce) according to manufacturer's instructions and injected into two rabbits (Harlan). Immunoglobulins specific for phospho-Thr 153 were affinity purified against the phospho-peptide by using the SulfoLink resin (Pierce) and purified according to standard protocols.
Immunoassay. Standard enzyme-linked immunosorbent assay (ELISA) procedure was used to test the specificity of the anti-xGEMC1 phospho-T153 antibodies.
Density substitution. Density substitution was performed as described 34 .
DNA spreading. Interphase egg extract was supplemented with sperm nuclei (2,000 nuclei μl -1 ), 300 ng μl -1 of r-xGEMC1 or r-xGEMC1 8ST/D and Biotin-dUTP (1/50, nature cell biology Roche) at 0 min. After 45 min, DNA replication was stopped and the DNA was processed as described 35 . Slides were prepared for immunofluorescence microscopy and probed with Streptavidin-594 conjugate (Invitrogen) and Biotinylated anti-streptavidin (Vector lab).
Immunoprecipitations. Protein-A-Sepharose (20 μl) bound to antibodies were incubated with 100 μl interphase extract at 4 °C for 45 min. Resin was harvested and washed extensively with EB buffer. Antigen-interactor proteins were eluted by incubating the resin in PBS containing 0.2% Sarkosyl for 30 min on ice. Samples were fractionated by 10% SDS-PAGE and processed for western blotting.
For immunoprecipitation, anti-xGEMC1 antibody (15 μg) was cross-linked to immobilized Protein A (Pierce) and added to 100 μl Xenopus extract. After incubation for 1 h at 4 °C, the beads were washed and the associated proteins were eluted by incubating the beads with Laemmli buffer. True blot kit (eBioscience) was used for western blots where needed, to eliminate background due to rabbit immunoglobulin chains.
Immunodepletions. To prepare TopBP1-and ORC1-depleted extracts, 300 μl interphase extract was incubated three times for 40 min with 70 μl protein A-Sepharose beads 4B fast flow (Sigma), coupled to 140 μl anti-TopBP1 serum and a 200 μl combination of anti-Orc1 and Orc2 serum at 4 °C for 2 h in the presence of 1 mM AEBSF (4-(2-aminoethyl)benzenesulphonyl fluoride hydrochloride). Mock depletions were performed using beads coupled to 200 μl pre-immune serum. The coupling to the beads was performed in PBS containing 0.2% NP-40. After the coupling reaction, the beads were first extensively washed with EB buffer containing 0.2% NP-40 and then with EB buffer. For xGEMC1 immunodepletion, 300 μl interphase extract was incubated three times for 30 min with an equivalent volume of A-Sepharose beads (1:1, extract: beads) coupled to 10 mg of purified anti-xGEMC1 antibodies per ml of resin.
DNA replication assays. Replication of sperm DNA (1-6,000 nuclei μl -1 ) and single-stranded M13 phage in egg extracts was measured by monitoring the incorporation of α 32 P-dATP or α 32 P-dCTP as previously described 13, 36, 37 .
TCA precipitation was used to quantify absolute amounts of replicated template as described 13, 36, 37 . The amount of replicated template was calculated assuming extract dATP concentration is 50-70 μM (usually 60 pmoles μl -1 of extract) using the following formula: pg DNA synthesized = (% dATP incorporated) × (pmoles dATP in the assay) × 4 × 330.
Embryo analysis. For histological examination, formaldehyde-fixed embryos were sectioned transversely and stained with ematossilin/eosin. Genomic DNA was obtained from five stage-37 embryos, using the QIAmp DNA mini Kit (Qiagen). DNA content was calculated based on absorbance (260 nm) measurement.
Apoptotic cell death in embryos was assayed for caspase activity by monitoring the cleavage of recombinant 35 S-labelled-poly-ADP-ribose polymerase (PARP) substrate (synthesised by IVTT), as previously shown 31 .
Cell culture and flow cytometry. NIH 3T3 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated donor calf serum and antibiotics. For fluorescence-activated cell sorting (FACS) analysis, cells were treated with 10 μM BrdU (Sigma) for 45 min, harvested, washed in PBS and fixed in cold 70% ethanol.
For propidium iodide staining, cells were washed twice in PBS. Pellets were re-suspended in 2 M hydrochloric acid and incubated for 30 min at room temperature. To neutralize the samples, acid was removed by centrifugation and the cells were washed twice with PBS and then once with neutralization buffer (PBS containing 0.1% BSA and 2% Tween 20). Resuspended pellets were stained with 50 μl fluorescein isothiocyanate (FITC)-conjugated rabbit anti-mouse antibody (DAKO) and treated with 50 μl ribonuclease (100 μg ml -1 , Sigma) for 15 min at room temperature. Finally, samples were incubated with 200 μl propidium iodide (50 μg ml -1 ) for 30 min at room temperature and analysed by FACS. siRNA. siRNA for Cdc45 and mGEMC1 were obtained from Invitrogen (mCdc45 and Gm606 SMART pool). siRNA oligonucleotides sequences: mCdc45: 5´-UUAUGCUUGAACCCAAACUGAAUGC-3ḿ GEMC1_1: 5´-CCAUUGAUGACACUCUACCAGCUAA-3ḿ GEMC1_2: 5´-AAUACGGGCAAUUAUAACUCUGGCC-3Ń egative-scrambled control (mock) siRNAwas purchased from Invitrogen. NIH 3T3 cells were transfected with siRNAs at a final concentration of 50 nM (mGEMC1) or 30 nM (mCdc45) with lipofectamine RNAiMAX (Invitrogen) according to manufacturer's instructions.
Transfections were performed twice at 24 h intervals for both mGEMC1 and mCdc45. After 48 h cells were harvested, lysed and 10 μg of total protein was resolved by SDS-PAGE gel. mCdc45 depletion was assessed by immunoblotting with anti-mouse Cdc45 antibodies.
RNA from NIH 3T3 cells was isolated using the RNeasy Micro kit (Qiagen). Mouse GEMC1 cDNA was isolated by RT-PCR using Qiagen one step RT-PCR.
Primers used for RT-PCR in this study: Fw_mGEMC1: 5´-AGAACAGCATTCTGCCTTGC-3Ŕ w_mGEMC1: 5´-CTAGGTCTGCTTAGGGACCCA-3F w_mGADPH: 5´-ACCCAGAAGACTGTGGATGG-3Ŕ w_mGADPH: 5´-CCCTGTTGCTGTAGCCCTAT-3ḿ GEMC1 RNAi rescue. Mouse cDNA GEMC1 (IMAGE clone 30639759) was amplified by PCR using a 5´ primer containing a NheI site: 5´-GCTAGCGGAAGATGCTGTGTTCCAGAACA-3´ and a 3´ primer containing a NotI recognition site: 5´-GCGGCCGCCTAGGTCTGCTTAGGGACCCA-3´. The PCR product was subcloned in a pGEM-T vector (Promega). The vector generated was used as a template for the PCR mutagenesis with the Phusion polymerase (Finnzymes) to generate a construct resistant to mGEMC1_siRNA1. The primers for the mutagenesis were designed to introduce a silent mutation in each codon of the target sequence of mGEMC1_siRNA1. The 5´ primer was: 5´-CTCTCCTCCGACGAGTTTTCCAAAGTGTTTGGAA-3´ and the 3´ primer was 5´-TAATTTCTTTGCTTTCTCTTCCAGACGTTTAACCA-3´. Wild-type and mutant mGEMC1 cDNAs were subcloned in a pTREHyg2-HA vector (BD Clontech). The empty vector, the vector encoding for wild-type mGEMC1 or the vector encoding for the RNAi resistant form of mGEMC1 were transfected in TET-OFF MEF/3T3 cells (BD Clontech) with Effectene reagent from Qiagen. Cells were split 48 h after transfection, and 24 h later 400 μg ml -1 hygromycin (Roche) was added to the media. Positive clones were selected and pooled to obtain the stable cell lines used in the experiments. Doxycycline (1μg ml -1 ) was added to the media to repress the expression of the exogenous gene. 35 S-labelled xGEMC1 proteins containing single serine or threonine to alanine substitutions at the indicated residues (T153A; S177A; S215A; T226A; S239A; S255A; S259A and T264A) produced in reticulocyte lysates and incubated with buffer (-), recombinant Cdk2/CyclinA (Cdk2-A) or Cdk2-CyclinE complexes (Cdk2/E). e) Autoradiograph of 35 S-labelled xGEMC1 containing multiple serine or threonine to alanine substitutions at the indicated residues (T153A; S177A; S215A; T226A; S239A; S255A; S259A and T264A) produced in reticulocyte lysates and incubated with buffer (-), recombinant Cdk2/CyclinA (Cdk2-A) or Cdk2-CyclinE complexes (Cdk2/E). See Supplementary Fig 6 for uncropped gels shown in this figure. 
